Novel Insights into DOCK4 as a Tumor Suppressor and Biomarker in Lung Cancer: Comprehensive Bioinformatics Analysis of LUAD and LUSC
In Silico
Novel Insights into DOCK4 as a Tumor Suppressor and Biomarker in Lung Cancer: Comprehensive Bioinformatics Analysis of LUAD and LUSC
Overview
Objectives
- Assess DOCK4 expression levels in LUAD and LUSC compared to normal lung tissues.
- Analyze the prognostic significance of DOCK4 expression in patient survival and disease outcomes.
- Explore mutation and methylation patterns of DOCK4 in lung cancer subtypes.
- Perform pathway enrichment and gene co-expression analyses to understand DOCK4-related signaling networks.
- Investigate the relationship between DOCK4 and immune cell infiltration to explore its potential role in tumor immunology.
- Propose DOCK4 as a candidate biomarker for diagnosis, prognosis, or therapeutic targeting in lung cancer.
- National University – Sudan